ANYA GREEN-ODLUM: Open Payments
NPI 1891947891 · DURHAM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,198 in 117 payments from 15 companies in 2025. Trend: 2023 $4,978 · 2024 $1,444 · 2025 $2,198
Food & beverage: $2,198
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $489 |
| Supernus Pharmaceuticals, Inc. | 30 | $309 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $227 |
| Neurocrine BioSciences, Inc. | 13 | $209 |
| Axsome Therapeutics, Inc. | 7 | $177 |
| Corium, LLC | 9 | $173 |
| E.R. Squibb & Sons, L.L.C. | 6 | $141 |
| Collegium Pharmaceutical, Inc. | 8 | $139 |
| Bausch Health US, LLC | 4 | $87 |
| Lundbeck LLC | 3 | $78 |
Products named: VRAYLAR, Qelbree, CAPLYTA, INGREZZA, Auvelity, Azstarys, COBENFY, Jornay PM.
Industry payments across NC — which companies pay providers there.
